Sterile isolation and cryopreservation of human adherent monocytes/macrophages from mononuclear cell apheresis

Stephen J Wagner1, Andrew Myrup, Yanwen Xu

  • 1American Red Cross, Biomedical Services, Jerome H. Holland Laboratory for the Biomedical Sciences, Blood & Cell Therapy Development, Rockville, Maryland 20855, USA. wagners@usa.redcross.org

Insights

A new method allows sterile isolation and cryopreservation of human monocytes/macrophages for therapeutic applications. These cells show viability and function after storage, supporting potential use in wound healing and tissue regeneration clinical trials.

Area of Science:

  • Immunology
  • Cell Biology
  • Regenerative Medicine

Background:

  • Monocytes/macrophages show therapeutic potential in wound healing, tissue regeneration, and cancer therapy.
  • Clinical application requires reliable methods for cell isolation and preservation.

Purpose of the Study:

  • To develop a method for sterile isolation and cryopreservation of human monocytes/macrophages.
  • To assess the viability and function of cryopreserved cells for potential clinical use.

Main Methods:

  • Isolation of adherent monocytes/macrophages from mononuclear cell apheresis units.
  • Sterile processing and cryopreservation of isolated cells.
  • Assessment of cell viability and phagocytic function post-thaw and short-term storage.

Main Results:

  • Developed a method yielding approximately 1 x 10^8 cells per preparation, with ~60% monocytes.
  • Cryopreservation up to 8 months maintained cell viability and phagocytic function.
  • Thawed cells retained viability and function for up to 4 hours at 1-6°C.

Conclusions:

  • A reproducible method for sterile isolation and cryopreservation of human monocytes/macrophages is established.
  • Cryopreserved monocytes/macrophages are suitable for clinical trials investigating therapeutic benefits.
  • These cells hold promise for enhancing chronic wound healing and nerve regeneration.

Related Concept Videos